bpc 157 tendon ligament healing human data Accelerating Healing: The Role of Collagen Peptides and BPC-157 Wolverine Stack: Healing Faster with

REDEFINE 1 (Garvey et al., NEJM 2025) is the only Phase 3 trial of an amylin + incretin co-administered combination, pairing cagrilintide 2.4 mg with semaglutide 2.4 mg

It works through melanocortin receptor activation, instead of tapping into hormonal pathways like ones responsible for testosterone production

Briefly, during the haemostasis phase, platelets are recruited or leak out of damaged vasculature and with the simultaneous activation of the coagulation cascade and formation of fibrin fibres, form a clot at the wound site 3

Bioavailability differences Injectable BPC-157 delivers essentially 100% of the administered dose to systemic circulation

Start low: Begin around 250 g daily for 12 weeks Increase gradually: Up to 500 g twice daily if tolerated Cycle: 46 weeks on, then take 24 weeks off This approach supports tendon, muscle, or ligament healing without overloading the system